Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

New monoclonal antibody for hospitalised COVID-19 patients approved by FDA

December 22, 2022 Medical Communications

The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …
News

Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery

December 21, 2022 Medical Communications

LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …
News
Press release

Kite set to acquire Tmunity Therapeutics

December 21, 2022 Medical Communications

Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …
News

Two biotech CEOs charged with defrauding investors over investigational HIV drug

December 21, 2022 Medical Communications

Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …
News

Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths

December 21, 2022 Medical Communications

A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …
News

Tamiflu manufacturers report shortages during high point of flu season

December 21, 2022 Medical Communications

The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …
News
carlos-muza-hpjsku2uysu-unsplash

ServBlock secures EU funding for pharma manufacturing data space

December 20, 2022 Medical Communications

ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system …
News

Abbott’s Eterna spinal cord stimulation system given FDA approval

December 20, 2022 Medical Communications

US-based Abbott Laboratories has announced that their Eterna spinal cord stimulation (SCS) system has been given approval by the FDA. …
News

Unison boss states Government has “adamantly refused” to engage in a “proper discussion” on pay ahead of Wednesday’s ambulance strikes

December 19, 2022 Medical Communications

Unison general secretary Christina McAnea has said that Wednesday’s ambulance strikes will go ahead without a “very firm commitment” on …
News

FDA approves first gene therapy to treat patients with high-risk, non-muscle-invasive bladder cancer

December 19, 2022 Medical Communications

The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive …
News

Anumana and Pfizer team up on AI-enabled ECG algorithm for detection of cardiovascular disease

December 16, 2022 Medical Communications

Anumana, an AI-driven health technology firm, has signed a multi-year deal with Pfizer in order to develop an AI electrocardiogram …
News

Eli Lilly and Sosei Heptares enter into multi-target collaboration and license agreement for diabetes and metabolic diseases

December 16, 2022 Medical Communications

Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and …
News

Johnson & Johnson and Merck’s Ebola vaccines show lasting protection

December 15, 2022 Medical Communications

The two Ebola vaccines developed by Johnson & Johnson and Merck appeared successful according to two studies: they both produced …
News

European Commission approves Dupixent® as the first and only targeted medicine for prurigo nodularis

December 15, 2022 Medical Communications

Regeneron Pharmaceuticals and Sanofi have announced that the European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in …
News

LumiraDx receives $14m in funding for point-of-care TB test

December 15, 2022 Medical Communications

UK-based point-of-care diagnostics company LumiraDx has been given $14m in grants from the Bill & Melinda Gates Foundation to support …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025